SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors FDA review of deramiocel remains active after the agency accepted a major amendment containing additional HOPE-3 open-label data and robustness analyses, extending the decision timeline. Traders are anticipating the data release, healthcare conferences and a potential approval, while skeptics remain focused on prior Advisory Committee concerns and the risk of another rejection; heavy short interest is fueling squeeze speculation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Escalating U.S.-Iran hostilities, including threats to the Strait of Hormuz, dominate discussion around DJT, with traders linking higher oil prices and inflation risks to broader market pressure. The community also debates Trumps Canada tariff policies and Venezuela oil deal, with supporters defending his agenda while critics question its economic impact.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

A reported BonkDAO security exploit that drained roughly $20 million in treasury tokens, along with concern about an Upbit delisting, is driving attention and bearish sentiment. Some traders are buying the selloff and betting on a security fix or broader Solana meme-coin rebound, while others question the teams response and fear further downside.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

The FTC and more than 20 states suing Amazon over alleged manipulation of advertising auctions and inflated fees is the dominant catalyst, pressuring shares and prompting debate over potential legal and advertising-business fallout. Traders remain divided between short-term bearish reactions and viewing the selloff as a buying opportunity, while some also point to AWSs expanding AI infrastructure partnership with Nvidia as a longer-term counterweight.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas addition of pedal-less Cybercabs to its Texas robotaxi roster and the upcoming Cybercab launch are driving intense attention, with traders positioning for continued momentum and a possible short squeeze. Others argue the event is largely priced in and could become a sell-the-news catalyst, citing unresolved questions about fleet utilization, autonomy performance, and Teslas fundamentals.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

A crypto-market rebound, enthusiasm over Robinhood Chain and tokenized-asset activity, and expectations for stronger prediction-market volumes are driving attention, with traders also speculating about a new product launch and other product expansions. The reaction is broadly bullish, though some traders remain cautious about crypto dependence, volatility, and repeated failures near resistance.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Geopolitical risk around the Iran conflict and potential Strait of Hormuz disruptions is driving attention to XOM as traders react to higher and volatile crude prices. The community is broadly bullish on energy and Exxons earnings and cash-flow leverage, although others expect de-escalation or a ceasefire to unwind the oil premium and pressure shares.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and growing expectations for a Federal Reserve rate hike are driving the main SPY discussion, with traders warning that expensive equities and elevated oil prices could pressure the index. Others argue the market is absorbing the macro risks, pointing to persistent buying, technical support, and sharp late-session rebounds; the result is a choppy, heavily debated bull-versus-bear tape.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dells scheduled fiscal Q2 earnings report is driving attention, with traders focused on whether AI-server demand, backlog, margins and guidance will support its strong run. Bulls expect a beat-and-raise, while bears cite elevated valuation, rising component costs and the risk of a sell-the-news reaction.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Rising global bond yieldsparticularly elevated U.S. and Japanese ratesalongside higher oil prices and increased expectations for a Federal Reserve hike are driving concern over QQQs growth-heavy valuations. Traders remain divided, with bears expecting a broader tech selloff while bulls point to QQQs resilience, support levels, and continued AI-related strength amid low-volume, choppy trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think Urogen Pharma (URGN) Could Surge 27.14%: Read This Before Placing a Bet

The consensus price target hints at a 27.1% upside potential for Urogen Pharma (URGN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

UroGen Pharma Stock Falls 5% After Signing Deals With IntraGel Therapeutics

(RTTNews) - Shares of UroGen Pharma Ltd. (URGN) are falling about 5 percent in Thursday morning trading after the company entered into an equity investment agreement and a strategic Option and Research License Agreement with IntraGel Therapeutics...

IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies

IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released...

Are You Looking for a Top Momentum Pick? Why Urogen Pharma (URGN) is a Great Choice

Does Urogen Pharma (URGN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of +26.32% and +16.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today? 

Equity

Investors showed confidence in healthcare improvements, strong biotech patents, and rising packaging demand. 


UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run

Key PointsAccording to this Form 4 filing, the CMO of UroGen Pharma sold 10,000 shares at $40.00 per share, totaling $400,000 in transaction proceeds...

Urogen Pharma (URGN) is a Great Momentum Stock: Should You Buy?

UroGen Pharma Reaches Analyst Target Price

In recent trading, shares of UroGen Pharma Ltd (Symbol: URGN) have crossed above the average analyst 12-month target price of $36.88, changing hands for $37.94/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va...

• Reported GAAP EPS of -$0.28 up 73.33% YoY
• Reported revenue of $72.46M up 199.22% YoY

UroGen Pharma Ltd. faces significant financial risks from its substantial accumulated deficit and reliance on single-source suppliers, alongside operational vulnerabilities due to its primary research and development operations in Israel.

UroGen Pharma Ltd. demonstrated strong revenue growth from the successful commercial launch of Zusduri while advancing its pipeline with positive clinical results for UGN-103 and strengthening its intellectual property portfolio.

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

UroGen Pharma Ltd

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info